• Home
  • About APS
  • APS News
  • Job Postings and Ads
  • Events and Education
  • Goverment Affairs
  • 2024 Annual Meeting
  • Education-OUD
  • Education-On Demand
  • Mental Health Resources

To Buy Vilitra Online Visit Our Pharmacy ↓

Click HERE To Buy Vilitra Online ↓




  • Vilitra Vs. Other Ed Medications: a Detailed Comparison

    Understanding Vilitra: Ingredients and Mechanism


    Vilitra, known for its active ingredient Vardenafil, is a potent PDE5 inhibitor. It works by increasing blood flow to the penis, facilitating erections in response to sexual stimulation. This medication offers a reliable solution by targeting the core physiological process involved in erectile dysfunction. Users often find Vilitra effective due to its focused action on the vascular system. Here’s a brief look at its key characteristics:

    Ingredient Mechanism of Action
    Vardenafil Enhances blood flow to the penis by inhibiting PDE5



    Comparing Efficacy: Vilitra Against Common Ed Medications



    Vilitra, primarily containing vardenafil, functions as a potent option for those seeking effective ED treatment. Its mechanism of increasing blood flow through the relaxation of muscle tissues in the penis, shares similarities with other medications like Viagra (sildenafil) and Cialis (tadalafil). However, Vilitra is noted for its unique formulation that can offer distinct response times and effectiveness for certain individuals.

    Compared to other ED medications, Vilitra's efficacy shines through its targeted approach. Clinical studies often highlight its reliable performance, with many users experiencing improved erections. While each medication has varied effects depending on individual responsiveness, Vilitra continues to be favored for its consistent results in promoting satisfactory sexual experiences.



    Onset and Duration: How Long Does Vilitra Last?


    Vilitra is recognized for its swift action, making it a popular choice for those seeking quick relief from erectile dysfunction. Typically, Vilitra takes effect within 30 to 60 minutes after ingestion. This rapid onset is instrumental for those who wish to maintain spontaneity in their intimate encounters, distinguishing Vilitra from other medications that may take longer to set in.

    Once Vilitra is active, its effects can last for approximately four to five hours. This duration provides a sufficient window for users to enjoy their experiences without the need for immediate re-dosing. Compared to other ED medications, which might have shorter or significantly longer durations, Vilitra strikes a balance well-suited for many individuals.

    The duration efficacy of Vilitra may vary due to factors like individual metabolism and overall health. It's important for users to consider these personal variables when evaluating how well Vilitra meets their needs. By understanding this balance of quick onset and moderate lasting power, individuals can better determine if Vilitra aligns with their expectations and requirements.



    Possible Side Effects: Vilitra Versus Other Ed Options



    When considering erectile dysfunction (ED) treatments, it's crucial to weigh potential side effects to make an informed choice. Vilitra, containing vardenafil, is known for its efficacy, but like any medication, it has its share of possible side effects. Commonly reported issues include headaches, flushing, dizziness, and nasal congestion, which are similar to those experienced with other ED treatments like Viagra (sildenafil) and Cialis (tadalafil).

    A compelling comparison reveals that while the side effects of Vilitra are generally mild, their intensity and occurrence can differ among individuals. For some, Vilitra might be the milder option compared to its counterparts; however, others might find its effects more pronounced. It's essential for users to understand how their bodies react to Vilitra versus other treatments, and seeking medical advice can help navigate these nuances.

    Ultimately, the choice of an ED medication hinges not only on effectiveness but also on tolerability. Understanding the side effect profile of Vilitra compared to other options can provide a clearer picture of what to expect. Personal health conditions and existing medications can influence which drug might be the best fit, underscoring the importance of personalized medical guidance when choosing an ED treatment.



    Cost Analysis: Vilitra and Its Market Competitors


    When considering the cost of erectile dysfunction (ED) treatments, Vilitra emerges as a notable option. Typically priced lower than some well-known brands like Viagra and Cialis, its affordability makes it an attractive choice for many patients. The economic appeal of Vilitra doesn't end with its price tag; its active ingredient, vardenafil, offers effective treatment at a reduced cost compared to other ED medications.

    | Medication | Active Ingredient | Average Cost per Tablet | |------------|-------------------|--------------------------| | Vilitra | Vardenafil | $10 | | Viagra | Sildenafil | $30 | | Cialis | Tadalafil | $35 |

    While cost is a decisive factor for many users, it’s crucial to weigh it against factors like efficacy and side effects. Market competitors may offer variations in performance and side effects, but Vilitra's affordability and effectiveness make it a compelling choice for those seeking value without compromising on results.



    Personal Experiences: What Users Say about Vilitra


    Many Vilitra users report a notable improvement in their sexual health, citing enhanced confidence and satisfaction. John's experience mirrors these sentiments; he notes that Vilitra has positively influenced his relationship by rekindling intimacy. Similarly, Marie's partner discovered a newfound spontaneity, fostering a deeper emotional connection.

    While some share accounts of mild headaches or flushing, these side effects often subside quickly and don't overshadow the benefits. Overall, user stories suggest that Vilitra plays a pivotal role in enriching their personal relationships and boosting quality of life.





ARIZONA PSYCHIATRIC SOCIETY 2024-2025 EXECUTIVE Board

President: Nicholas Ahrendt, MD President-Elect: Margaret Balfour, MD, PhDVice President: Brenner Freeman, MDTreasurer: Robert Rymowicz, DOSecretary: Chiranjir "Ravi" Narine, MD Co Resident-Fellow Member Representatives: Nehal Samra, MD Creighton Matthew Mitchell, MD UA-PhoenixGagan Singh, MD UA-Tucson
APA Assembly Representatives: Jason Curry, DO (serves term concluding 2024) Jasleen Chhatwal, MBBS, MD (two-year term concluding 2024)Payam Sadr, MD (one-year term concluding 2024) Past President Gagandeep Singh, MD, DFAPA Stephen "Larry" Mecham, DO The Society thanks these members for their leadership.

Celebrating our members

Chase was born and raised in Phoenix, AZ, and attended ASU for a bachelor’s degree in business then attended KCUMB for medical school in Kansas City. He was excited to return home to AZ when he found out he'd been matched with UACOM – Phoenix for his psychiatry residency.
He was first drawn to the field of psychiatry during his years in medical school as he found the psychiatric subject matter and the patients to be the most engaging and interesting of all his studies. He quickly came to realize that without a healthy mind, one is unable to thoroughly experience life constructive way. He wanted to be the person to help those struggling with mental illness as he found these cases and experiences to be the most rewarding in medicine.
Dr. Crookham said he has been lucky enough to have been matched at a great psychiatric residency program where he gets to learn from great mentors and colleagues every day. He believes his passion for psychiatry along with the relationships he's developed with his colleagues and mentors will carry him to be a lifelong learner and devoted psychiatrist for his future patients.
Meghan is a graduate of Lincoln Memorial University, DeBusk College of Osteopathic Medicine.
She received her Bachelor of Arts from the University of Denver in French and Biology with a concentration in Cognitive Neuroscience.
She is currently a chief resident at UACOM-Tucson in her final year of psychiatry training and will be starting a fellowship in Addiction Medicine at the University of Arizona, Tucson in July.
Her professional interests include physician mental health, adult consult liaison and addiction psychiatry.
In her personal time, she enjoys home design projects, spending time with family, learning about plants, and exploring new places.
Dr. Hintze is currently honeymooning in Japan! Congratulations!!
Danny is originally from Phoenix. Graduated from Brophy, ASU, and UA Tucson Medical School. His background is in economics, philosophy of science, and rational decision-making.
He was drawn to psychiatry because of the conceptual complexity and the profound impact even relatively simple pharmaceutical, medical, and psychotherapeutic interventions can have to empower patients and their families.
As a mentor, he wanted to recognize the many people within the Arizona Medical Community, particularly at UA Tucson, Valleywise, and within organized medicine who have worked to protect and promote medicine as a joyful, compassionate, and healing experience for patients and for all of us who help care for them.

ARIZONA PSYCHIATRIC SOCIETY past presidents

Otto L. Bendheim, M.D. 1960-1961Warren S. Williams, M.D. 1961-1963T. Richard Gregory, M.D. 1963-1964Boris Zemsky, M.D. 1964-1965 Hal J. Breen, M.D. 1965-1966Joseph M. Green, M.D. 1966-1967Irene M. Josselyn, M.D. 1967-1968Hubert R. Estes, M.D. 1968-1969Richard H. Bruner, M.D. 1969-1970Thomas F. Kruchek, M.D. 1970-1971David S. Burgoyne Sr., M.D. 1971-1972Marshall W. Jones, M.D. 1972-1973Harold D. Haeussler, M.D. 1973-1974William B. Haeussler, M.D. 1974-1975Edward S. Gelardin, M.D. 1975-1976Hugo L. Cozzi, M.D. 1976-1977Robert F. Meyer, M.D. 1977-1978James E. Campbell, M.D. 1978-1979Stuart M. Gould, M.D. 1979-1980Elliot M. Heiman, M.D. 1980-1981Stephen V. Shanfield, M.D. 1981-1982Jerry A. Biggs, M.D. 1982-1983Robert C. Shapiro, M.D. 1983-1984Dennis C. Westin, M.D. 1984-1985John H. Jarvis, M.D. 1985-1986James G. Hill, M.D. 1986-1987Robert P. Bevan, M.D. 1987-1988Eugene J. Kinder, M.D. 1988-1989 James M. Campbell, M.D. 1989-1990David S. Burgoyne II, M.D. 1990-1991
Stuart W. Hollingsworth, M.D. 1991-1992Kevin J. Leehey, M.D. 1992-1993Stephen S. Brockway, M.D. 1993-1994Michael H. Stumpf, M.D. 1994-1995Lauro Amezcua-Patino, M.D. 1995-1996David S. Burgoyne II, M.D. 1997-1998Glenn Lippman, M.D. 1998-1999Lisa Jones, M.D. 1999-2000David J. Coons, M.D. 2000-2001James M. Campbell, M.D. 2001-2002Bradley Johnson, M.D. 2002-2003David W. Leicken, M.D. 2003-2004Thomas N. Crumbley, M.D. 2004-2006Jeffrey L. Schwimmer, M.D., M.P.H. 2006-2007Stephen O. Morris, M.D. 2007-2008Jack L. Potts, M.D. 2008-2009Elizabeth A. Kohlhepp, M.D. 2009-2010Michael E. Brennan, M.D. 2010-2011Gretchen Alexander, M.D. 2011-2012Tariq M. Ghafoor, M.D. 2012-2013Joanna K. Kowalik, M.D., M.P.H., 2013-2014Payam M. Sadr, M.D., 2014-2015Roland Segal, M.D., 2015-2016Gurjot Marwah, M.D., 2016-2017Aaron Wilson, M.D., 2017-2018Mona Amini, M.D., 2018-2019 Don J. Fowls, M.D., 2019-2020 Jasleen Chhatwal, M.B.B.S., M.D., 2020-2022 Stephen Larry Mecham, DO, 2022-2023 Gagandeep Singh, MD, DFAPA 2023-2024
Main Menu
  • Home
  • About APS
  • APS News
  • Job Postings and Ads
  • Events and Education
  • 2023 Annual Meeting
  • Education-OUD
  • Education-On Demand
  • Mental Health Resources
Contact Information
Address: 2401 West Peoria Avenue, Suite 315 Phoenix, Arizona 85029
Phone: 602-909-4388
E-mail: admin@azpsych.org
Social
The Arizona Psychiatric Society is committed to ensuring the accessibility of its website to people with disabilities. If you have trouble accessing any of the Arizona Psychiatric Society's resources, please contact us at admin@azpsych.org for assistance Copyright © 2020 Network Solutions, LLC, A Web.com Company. All rights reserved.

We use cookies to enable essential functionality on our website, and analyze website traffic. By clicking Accept you consent to our use of cookies. Read about how we use cookies.

Your Cookie Settings

We use cookies to enable essential functionality on our website, and analyze website traffic. Read about how we use cookies.

Cookie Categories
Essential

These cookies are strictly necessary to provide you with services available through our websites. You cannot refuse these cookies without impacting how our websites function. You can block or delete them by changing your browser settings, as described under the heading "Managing cookies" in the Privacy and Cookies Policy.

Analytics

These cookies collect information that is used in aggregate form to help us understand how our websites are being used or how effective our marketing campaigns are.